Saliva as a non-invasive tool for monitoring oxidative stress in swimmers athletes performing a VO


Journal

Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R

Informations de publication

Date de publication:
15 Aug 2020
Historique:
received: 03 02 2020
revised: 24 03 2020
accepted: 26 03 2020
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 26 1 2021
Statut: ppublish

Résumé

Biomarkers of oxidative stress are generally measured in blood and its derivatives. However, the invasiveness of blood collection makes the monitoring of such chemicals during exercise not feasible. Saliva analysis is an interesting approach in sport medicine because the collection procedure is easy-to-use and does not require specially-trained personnel. These features guarantee the collection of multiple samples from the same subject in a short span of time, thus allowing the monitoring of the subject before, during and after physical tests, training or competitions. The aim of this work was to evaluate the possibility of following the changes in the concentration of some oxidative stress markers in saliva samples taken over time by athletes under exercise. To this purpose, ketones (i.e. acetone, 2-butanone and 2-pentanone), aldehydes (i.e. propanal, butanal, and hexanal), α,β-unsaturated aldehydes (i.e. acrolein and methacrolein) and di-carbonyls (i.e. glyoxal and methylglyoxal) were derivatized with 2,4-dinitrophenylhydrazine, and determined by ultra-high performance liquid chromatography coupled to diode array detector. Prostaglandin E

Identifiants

pubmed: 32456903
pii: S0039-9140(20)30270-8
doi: 10.1016/j.talanta.2020.120979
pii:
doi:

Substances chimiques

Biomarkers 0
Isoprostanes 0
Prostaglandins 0
Glyoxal 50NP6JJ975

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120979

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Denise Biagini (D)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124, Pisa, Italy.

Tommaso Lomonaco (T)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124, Pisa, Italy. Electronic address: tommaso.lomonaco@unipi.it.

Silvia Ghimenti (S)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124, Pisa, Italy.

Jonathan Fusi (J)

Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56124, Pisa, Italy.

Eugenio Cerri (E)

Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56124, Pisa, Italy.

Francesca De Angelis (F)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124, Pisa, Italy.

Francesca Giuseppa Bellagambi (FG)

Univ Lyon, CNRS, Université Claude Bernard Lyon 1, Institut de Sciences Analytiques, UMR 5280, 5 rue de la Doua, F-69100, Villeurbanne, France.

Camille Oger (C)

Institut des Biomolécules Max Mousseron, IBMM, Université de Montpellier, CNRS, ENSCMFaculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, F-34093, Montpellier Cedex 05, France.

Jean Marie Galano (JM)

Institut des Biomolécules Max Mousseron, IBMM, Université de Montpellier, CNRS, ENSCMFaculté de Pharmacie, 15 avenue Charles Flahault, BP 14491, F-34093, Montpellier Cedex 05, France.

Emilia Bramanti (E)

Institute of Chemistry of Organometallic Compounds, CNR, Via Giuseppe Moruzzi 3, 56124, Pisa, Italy.

Ferdinando Franzoni (F)

Department of Clinical and Experimental Medicine, University of Pisa, Via Roma 67, 56124, Pisa, Italy.

Roger Fuoco (R)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124, Pisa, Italy.

Fabio Di Francesco (F)

Department of Chemistry and Industrial Chemistry, University of Pisa, Via Giuseppe Moruzzi 13, 56124, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH